Sanofi-Aventis vaccine Adacel launches in the U.S. for booster immunization against tetanus, diphtheria and acellular pertussis in individuals aged 11-64, the company reports July 25. List price for Adacel is $33.50 per dose; vaccine is provided in packages containing 10-single dose vials. The Tdap vaccine cleared FDA June 10 with a postmarketing commitment for a 16,000-patient epidemiological safety surveillance study (1"The Pink Sheet," June 20, 2005, p. 20)...
You may also be interested in...
Sanofi-Aventis' postmarketing commitments for Adacel include a 16,000-patient epidemiologic safety surveillance study of the tetanus, diphtheria and acellular pertussis vaccine
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.